Treatment
-
The DCIS DilemmaDuctal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Preserving the FutureYoung adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
Forward Look
There Goes the NeighborhoodQ&A with scientist Zena Werb on cancer, immunity and the microenvironment.
by Chris Palmer
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
-
Forward Look
Cancer Treatment Can Reactivate Hepatitis BResearchers make the case for screening cancer patients for hepatitis B before treatment.
by Yasmine Iqbal
-
Forward Look
First Biosimilar Drug Approved in U.S.New drugs will offer same effectiveness, but at a lower cost.
by Stephen Ornes
-
From the Editor-in-Chief
The Promise of Precision MedicineThe impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
-
A Dose of PrecisionStereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
